1
|
Chene G, Cerruto E, Moret S, Nohuz E. Could the anatomic location of Essure® device explain the impairment of quality of life? Minerva Obstet Gynecol 2022; 74:123-129. [PMID: 35421915 DOI: 10.23736/s2724-606x.21.04728-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Since health-related quality of life (HRQL) could improve after removal of Essure® (Bayer, Leverkusen, Germany) inserts in symptomatic patients, we aimed to assess whether such postoperative enhancement was linked to the anatomic placement of the device. METHODS Correct and incorrect placed Essure® (Bayer) were identified in the electronic database of the French cohort Ablimco (cohort of consenting patients with laparoscopic Essure® [Bayer] removal). HRQL, pain and heavy menstrual bleeding were evaluated after Essure® (Bayer) removal with validated quality of life questionnaires (Short Form12 Questionnaire, Visual Analogue Scale, French version of the McGill Pain Questionnaire and the pictorial blood assessment chart PBAC). RESULTS Sixty-five patients were included in the study divided in two groups (group A with correct placement: 45 patients and group B with incorrect placement: 20 patients). HRQL and Pain Index were improved in both groups at 6 months post-surgery. There was not any statistically significant difference between group A and B. The PBAC score increased at 6 months postoperatively in group A and B without any statistically significant difference between them. CONCLUSIONS Postoperative improvement of quality of life and pain index was similar whatever the position of the implant. This suggests that symptomatology and quality of life are not related to the anatomic location of the Essure® (Bayer) implants.
Collapse
Affiliation(s)
- Gautier Chene
- Department of Gynecology, Hôpital Femme Mère Enfant - HFME, University of Lyon, Lyon, France - .,Claude Bernard University of Lyon1, Lyon, France -
| | - Emanuele Cerruto
- Department of Gynecology, Hôpital Femme Mère Enfant - HFME, University of Lyon, Lyon, France
| | - Stéphanie Moret
- Department of Gynecology, Hôpital Femme Mère Enfant - HFME, University of Lyon, Lyon, France
| | - Erdogan Nohuz
- Department of Gynecology, Hôpital Femme Mère Enfant - HFME, University of Lyon, Lyon, France
| |
Collapse
|
2
|
Chene G, Cerruto E, Moret S, Lebail-Carval K, Chabert P, Mellier G, Nohuz E, Lamblin G, Clark TJ. Quality of life after laparoscopic removal of Essure ® sterilization devices. Eur J Obstet Gynecol Reprod Biol X 2019; 3:100054. [PMID: 31404292 PMCID: PMC6687440 DOI: 10.1016/j.eurox.2019.100054] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2019] [Revised: 05/11/2019] [Accepted: 05/19/2019] [Indexed: 12/04/2022] Open
Abstract
Objective(s) To assess changes in quality of life after laparoscopic removal of Essure® sterilization devices (Bayer AG, Leverkusen, Germany). Study Design In this prospective observational study in an academic research hospital, 80 women with new or worsening symptoms since placement of Essure® sterilization devices undergoing subsequent surgical removal were included. Laparoscopic removal of Essure® devices and salpingectomy with or without cornual excision were performed. Concomitant uterine procedures could be associated where indicated for gynaecological complaints. Comparison using the T student test for coupled series was done in this before-and-after study. Results Health related quality of life (HRQL) was the primary outcome measured by the Short Form 12 (SF-12) questionnaire and a global 10 cm visual analogue scale (VAS). Secondary outcomes included assessment of pain, using continuous (VAS) and ordinal scales (Modified McGill Pain Questionnaire), menstrual bleeding (pictorial blood loss assessment chart (PBAC) score) and surgical feasibility and safety. There was a significant improvement in quality of life in both mental and physical health aspects of the SF-12 (34.02 (+/−1.19) vs. 49.61 (+/−1.42, P < .0001) and 36.55 (+/−0.99) vs. 43.32 (+/−1.18, P < .0001 respectively) as well as global VAS assessment (+2.91 (SD +/−0.27)) at the end of the first post-operative month. These improvements were maintained at three and six months. Mean pain decreased at one month following surgery compared to baseline (VAS 3.6 (+/−0.36) to 1.4 (+/−0.25), P < .0001 and McGill pain score 18.70 (+/−1.88) to 4.73 (+/−0.90), P < .0001). Improvements of a similar magnitude were observed when analysis was restricted to the 47 women without concomitant uterine surgery. No significant changes in bleeding were seen following of Essure® device removal. Planned procedures were all successfully completed. Conclusion Laparoscopic removal of Essure® devices in symptomatic women is technically successful and associated with short and medium-term improvement in quality of life as well as reduction in pelvic pain.
Collapse
Affiliation(s)
- Gautier Chene
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France.,Claude Bernard University of Lyon 1, EMR 3738, 69000 Lyon, France
| | - Emanuele Cerruto
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Stephanie Moret
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Karine Lebail-Carval
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Philippe Chabert
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Georges Mellier
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Erdogan Nohuz
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - Gery Lamblin
- Department of Gynecology, Hôpital Femme Mère Enfant, HFME, 59 boulevard Pinel, Universitary hospital of Lyon, 69000 Lyon, France
| | - T Justin Clark
- Department of Obstetrics and Gynaecology, Birmingham Women's and Children's Hospital, Birmingham, B15 2TG, UK
| |
Collapse
|